Christian Dejaco News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Christian dejaco. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Christian Dejaco Today - Breaking & Trending Today

EULAR 2024 Preview: What's Not to Miss?

Experts give their top picks and hot tips on data being presented at the upcoming European Congress of Rheumatology taking place on June 12-15 in Vienna, Austria. ....

Georg Schett , Josefs Smolen , Christian Dejaco , Frank Buttgereit , Caroline Ospelt , German Rheumatism Research Center , University Hospital Zurich , Congress Committee Scientific Programme , European Alliance Of Associations , European Congress , University Of Graz , European Alliance , Rheumatology Annual Meeting , From June , Medscape Medical News , Congress Committee , Scientific Programme Chair Caroline Ospelt , Abstract Chair Christian Dejaco , Medical University , Abstract Plenary , Cell Therapy , What Is New , Past President , Emeritus Professor , Rheumatology Josef , Rheumatic Diseases ,

Updated imaging recommendations for the management of large vessel vasculitis

Updated imaging recommendations for the management of large vessel vasculitis
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United States , Christian Dejaco , American Rheumatology Association , Rheumatic Diseases ,

EULAR: MRI, PET can be used 'as an alternative' to ultrasound for cranial arteries in GCA

MRI and PET scans are viable alternatives to ultrasound for cranial arteries in patients with suspected giant cell arteritis, according to a 2023 update of EULAR’s recommendations for imaging in large vessel vasculitis. ....

Byrob Volansky , Shenaz Bagha , Christian Dejaco , University Of Graz , Eli Lilly Co , Eli Lilly , Medical University ,

EULAR recommendations for giant cell arteritis, PMR prioritize remission as target

The treatment target for patients with giant cell arteritis or polymyalgia rheumatica should be remission, with vascular damage prevention taking priority in patients with GCA, according to treat-to-target recommendations from EULAR. “Treatment targets have already been defined in several areas of rheumatology, including rheumatoid arthritis (RA), spondyloarthritis (SpA), gout and systemic ....

Christian Dejaco , University Of Graz , Medical University , Ann Rheum Dis ,